| |
Men
|
Women
|
|---|
|
Total, N (row%)
|
24,540 (41.2)
|
35,064 (58.8)
|
|---|
| |
n (col%)
|
n (col%)
|
|---|
|
Age
|
|
25–34
|
2,306 (9.4)
|
3,697 (10.5)
|
|
35–44
|
5,290 (21.6)
|
7,242 (20.7)
|
|
45–54
|
7,133 (29.1)
|
9,946 (28.4)
|
|
55–64
|
6,700 (27.3)
|
9,063 (25.9)
|
|
65–79
|
3,111 (12.7)
|
5,116 (14.6)
|
|
Cardiovascular riska
|
|
Low (<10 %)
|
7,661 (38.9)
|
24,192 (77.1)
|
|
Moderate (10–20 %)
|
6,290 (31.9)
|
5,378 (17.1)
|
|
High (>20 %)
|
5,745 (29.2)
|
1,798 (5.7)
|
|
Missing
|
4,844 [19.7]
|
3,696 [10.5]
|
|
Diabetes
|
552 (2.3)
|
710 (2.0)
|
|
BP-lowering medications, any fill in past year
|
4,870 (19.9)
|
6,477 (18.5)
|
|
Systolic blood pressure
|
|
≤140
|
18,265 (84.7)
|
28,956 (88.6)
|
|
141–160
|
2,817 (13.1)
|
3,103 (9.5)
|
|
161–180
|
438 (2.0)
|
537 (1.6)
|
|
>180
|
56 (0.3)
|
91 (0.3)
|
|
Missing
|
2,964 [12.1]
|
2,377 [6.8]
|
|
Total cholesterol
|
|
<200
|
6,745 (46.5)
|
8,781 (41.0)
|
|
200–239
|
5,508 (38.0)
|
8,352 (39.0)
|
|
≥240
|
2,256 (15.6)
|
4,273 (20.0)
|
|
Missing
|
10,031 [40.9]
|
13,658 [39.0]
|
|
HDL cholesterol
|
|
<40
|
2,534 (17.5)
|
770 (3.6)
|
|
40–59
|
8,135 (56.1)
|
7,569 (35.4)
|
|
≥60
|
3,838 (26.5)
|
13,060 (61.0)
|
|
Missing
|
10,033 [40.9]
|
13,665 [39.0]
|
|
LDL cholesterol
|
|
<100
|
2,207 (20.7)
|
3,721 (24.1)
|
|
100–129
|
3,945 (37.1)
|
5,808 (37.6)
|
|
130–159
|
3,094 (29.1)
|
4,049 (26.2)
|
|
160–189
|
1,101 (10.3)
|
1,467 (9.5)
|
|
≥190
|
302 (2.8)
|
401 (2.6)
|
|
Missing
|
13,891 [56.6]
|
19,618 [56.0]
|
|
BMI
|
|
<25
|
4,761 (22.8)
|
12,481 (38.2)
|
|
25–29.9
|
9,220 (44.1)
|
9.646 (29.5)
|
|
≥30
|
6,913 (33.1)
|
10,545 (32.3)
|
|
Missing
|
3,646 [14.9]
|
2,392 [6.8]
|
|
Current smoker
|
2,188 (13.5)
|
3,130 (9.1)
|
|
Missing
|
843 [3.4]
|
587 [1.7]
|
|
RUB
|
|
0 = No diagnoses
|
2,687 (11.0)
|
2,097 (6.0)
|
|
1 = Low
|
3,519 (14.3)
|
4,158 (11.9)
|
|
2
|
4,697 (19.1)
|
5,248 (15.0)
|
|
3
|
11,929 (48.6)
|
19,557 (55.8)
|
|
4
|
1,355 (5.5)
|
3,450 (9.8)
|
|
5 = High
|
353 (1.4)
|
554 (1.6)
|
|
Health plan
|
|
Medicare
|
3,309 (13.5)
|
5,382 (15.4)
|
|
Medicaid/Basic Health
|
315 (1.3)
|
673 (1.9)
|
|
Commercial
|
19,945 (81.3)
|
27,699 (79.0)
|
|
Private pay
|
971 (4.0)
|
1,310 (3.7)
|
|
Annual average primary care visits, past 5 years
|
|
<1
|
8,257 (33.7)
|
6,572 (18.7)
|
|
1 to <2
|
9,326 (38.0)
|
12,055 (34.4)
|
|
2 to <3
|
4,130 (16.8)
|
8,255 (23.5)
|
|
≥3
|
2,827 (11.5)
|
8,182 (23.3)
|
|
Residence
|
|
Rural
|
660 (2.7)
|
914 (2.6)
|
|
Urban
|
23,880 (97.3)
|
34,150 (97.4)
|
|
Race
|
|
White
|
14,866 (84.0)
|
25,805 (82.8)
|
|
Asian
|
1,418 (8.0)
|
3,105 (10.0)
|
|
Black
|
916 (5.2)
|
1,301 (4.2)
|
|
Mixed race/Other
|
490 (2.8)
|
951 (3.1)
|
|
Missing
|
6,850 [27.9]
|
3,902 [11.1]
|
|
Neighborhood-level variables
|
|
Median household income
|
|
<$40,000
|
5,371 (21.9)
|
7,643 (21.9)
|
|
$40,000 to <$60,000
|
11,394 (46.5)
|
16,410 (46.9)
|
|
$60,000 to <$80,000
|
5,606 (22.9)
|
8,014 (22.9)
|
|
≥$80,000
|
2,114 (8.6)
|
2,913 (8.3)
|
|
Missing
|
55 [0.2]
|
84 [0.2]
|
|
Education, % with some college
|
|
<50 %
|
2,687 (11.0)
|
3,953 (11.3)
|
|
50 % to <60 %
|
4,096 (16.7)
|
5,968 (17.1)
|
|
60 % to <70 %
|
6,407 (26.2)
|
9,215 (26.3)
|
|
70 % to <80 %
|
5,973 (24.4)
|
8,554 (24.5)
|
|
≥80 %
|
5,319 (21.7)
|
7,289 (20.8)
|
|
Missing
|
58 [0.2]
|
85 [0.2]
|
- aCVD Risk score based on BMI-based risk calculations. When BMI-risk was missing, we used lab-based risk calculations (n = 698). The CVD risk equations are as follows:
- BMI-based CVD Risk Equations:
-
Male, not treated with antihypertensive medications
- 100*(1-(0.88431^(exp([3.11296*ln(AGE) + 0.79277*ln(BMI) + 1.85508*ln(SBP) + 0.70953*SMOKE + 0.53160*DIAB] -23.9388))))
-
Male, treated with antihypertensive medications
- 100*(1-(0.88431^(exp([3.11296* ln(AGE) + 0.79277* ln(BMI) + 1.92672* ln(SBP) + 0.70953* SMOKE + 0.53160* DIAB] -23.9388))))
-
Female, not treated with antihypertensive medications
- 100*(1-(0.94833^(exp([2.72107* ln(AGE) + 0.51125* ln(BMI) + 2.81291* ln(SBP) + 0.61868* SMOKE + 0.77763* DIAB] -26.0145))))
-
Female, treated with antihypertensive medications
- 100*(1-(0.94833^(exp([2.72107* ln(AGE) + 0.51125* ln(BMI) + 2.88267* ln(SBP) + 0.61868* SMOKE + 0.77763* DIAB] -26.0145))))
- Lab-based CVD Risk Equations:
-
Male, not treated with antihypertensive medications
- 100*(1-(0.88936^(exp([3.06117*ln(AGE) + 1.12370*ln(TC)+−0.93263*ln(HDL) + 0.65451*SMOKE + 0.57367*DIAB + 1.93303* ln(SBP)]-23.9802))))
-
Male, treated with antihypertensive medications
- 100*(1-(0.88936^(exp([3.06117*ln(AGE) + 1.12370*ln(TC)+−0.93263*ln(HDL) + 0.65451*SMOKE + 0.57367*DIAB + 1.99881* ln(SBP)]-23.9802))))
-
Female, not treated with antihypertensive medications
- 100*(1-(0.95012^(exp([2.32888*ln(AGE) + 1.20904*ln(TC)+−0.70833*ln(HDL) + 0.52873*SMOKE + 0.69154*DIAB + 2.76157* ln(SBP)] -26.1931))))
-
Female, treated with antihypertensive medications
- 100*(1-(0.95012^(exp([2.32888*ln(AGE) + 1.20904*ln(TC)+−0.70833*ln(HDL) + 0.52873*SMOKE + 0.69154*DIAB + 2.82263* ln(SBP)] -26.1931))))
